Vita Life Sciences Limited (ASX:VLS – Get Rating) announced a final dividend on Wednesday, March 15th, MarketIndexAU reports. Shareholders of record on Thursday, April 13th will be paid a dividend of 0.033 per share on Thursday, April 13th. This represents a yield of 2.08%. The ex-dividend date of this dividend is Thursday, March 16th. This is an increase from Vita Life Sciences's previous final dividend of $0.03.
Vita Life Sciences Price Performance
The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.57 and a current ratio of 2.77.
Get
Vita Life Sciences alerts:
About Vita Life Sciences
(Get Rating)
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; pregnancy and breastfeeding; men, women, and children's health; antioxidant; and bones and joints.
Recommended Stories
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
- Lennar Raises The Roof With Q1 Results: Don't Chase It Higher
- Universal Insurance: Navigating Florida's Insurance Crisis
Receive News & Ratings for Vita Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vita Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
维塔生命科学有限公司据MarketIndexAU报道,(ASX:VLS-GET Rating)于3月15日(星期三)宣布了末期股息。4月13日(星期四)登记在册的股东将于4月13日(星期四)获得每股0.033欧元的股息。这意味着收益率为2.08%。本次股息除息日期为3月16日星期四。这比维塔生命科学之前0.03美元的末期股息有所增加。
VITA生命科学性价比
该公司的债务权益比率为1.65,速动比率为1.57,流动比率为2.77。
到达
维塔生命科学警报:
关于维塔生命科学
(获取评级)
维塔生命科学有限公司是一家医疗保健公司,在澳大利亚、新加坡、马来西亚、泰国、越南、印度尼西亚和中国从事维生素和补充剂的配方、包装、分销和销售。该公司还提供各种矿物质、草药和超级食品。此外,它还提供治疗领域的产品,如神经系统;营养产品和营养油;免疫;头发、皮肤和指甲;肝脏和消化;体重管理;心血管健康;疼痛和炎症;怀孕和哺乳;男性、女性和儿童健康;抗氧化剂;以及骨骼和关节。
推荐故事
- SentinelOne:网络安全股的逆转
- 2023年,Sportradar Group A成长型股票值得押注吗?
- 强力指引称波音已做好起飞准备
- Lennar以第一季度业绩提升屋顶:不要追得更高
- 万能保险:驾驭佛罗里达州的保险危机
接受《维塔生命科学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Vita生命科学和相关公司的最新新闻和分析师评级的每日简要摘要。